Paper Discussed: Hermann MM, van Asten F, Muether PS, Smailhodzic D, Lichtner P, Hoyng CB, Kirchhof B, Grefkes C, den Hollander AI, Fauser S
Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
Ophthalmology. 2014 Apr;121(4):905-10.[PubMed]
Guest: Sascha Fauser, MD
Department of Ophthalmology
University Hospital of Cologne